Value of medicines

At Novartis, we believe that the cost of a drug must always be viewed in terms of the value provided to patients and their families, to payors, and to society.

We are a leader in developing innovative therapies, and we are also a leader in generic pharmaceuticals - which means we can help to make high-quality medicines more widely available by making them more affordable.

We conduct and support extensive health economic research to more fully understand the social and financial impact of disease, and, by extension, to demonstrate the value of our medicines.